FormWeb • brexucabtagene autoleucel

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search by class Show Therapeutic Classes

Add Formweb to your mobile device

Android iOS

Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

brexucabtagene autoleucel

brexucabtagene autoleucel

Non-formulary Anti-Neoplastic Formulary

Drug Name	Form	Strength	Formulary Unrestricted	Formulary Restricted	Non-Formulary	Interchange
Tecartus	SUSPENSION, INTRAVENOUS	2 x 10^6 CAR T-cells/kg/dose

Comments:

Eligible patients should be referred to regional Tecartus administration sites.

Reviewed: July 2021 (Tecartus)

Last updated: Feb. 21, 2026

Black Box Warning: Cytokine Release Syndrome, Neurologic Toxicities, And Secondary Hematological Malignancies

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.